IC
IMGN

Ikarian Capital’s Immunogen Inc IMGN Stock Holding History

Ikarian Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-456,800
Closed -$13.5M – 189
2023
Q4 		$13.5M Buy
456,800
+453,232
+12,703% +$9.03M 1.27% 24
2023
Q3 		$5.66M Sell
3,568
-346,432
-99% -$5.76M 0.68% 45
2023
Q2 		$6.6M Buy
350,000
+243,400
+228% +$2.87M 1.05% 30
2023
Q1 		$409K Buy
+106,600
New +$454K 0.09% 99

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ikarian Capital's IMGN Position: Q1 2024 in Review

Ikarian Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 90,162 shares — an estimated $2.67M sold.

Ikarian Capital first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $8.45M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Ikarian Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Ikarian Capital sold 90,162 Immunogen Inc shares in Q1 2024, an estimated $2.67M.
  • Ikarian Capital first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Ikarian Capital's Immunogen Inc position peaked at $8.45M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Ikarian Capital's 13F filing for Q1 2024, filed 15 May 2024.